# XTL Biopharmaceuticals Ltd. (XTLB)

> Healthcare · IL · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/XTLB/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2024 | $ 474.0K | $ -1.08M | $ 0 | $ 138.0K | $ 5.44M |
| 2023 | $ 0 | $ -1.93M | $ 0 | $ 0 | $ 2.22M |
| 2022 | $ 0 | $ -1.51M | $ 0 | $ 0 | $ 4.00M |
| 2021 | $ 0 | $ 1.20M | $ 0 | $ 0 | $ 5.33M |
| 2020 | $ 0 | $ -1.64M | $ 0 | $ 0 | $ 6.25M |
| 2019 | $ 0 | $ -1.74M | $ 0 | $ 0 | $ 6.98M |
| 2018 | $ 0 | $ 3.94M | $ 0 | $ 0 | $ 8.32M |
| 2017 | $ 0 | $ -1.05M | $ -728.8K | $ 0 | $ 3.62M |
| 2016 | $ 0 | $ -3.50M | $ -1.50M | $ 0 | $ 2.69M |
| 2015 | $ 0 | $ -6.05M | $ -2.13M | $ 0 | $ 4.89M |
| 2014 | $ 0 | $ -3.57M | $ -3.50M | $ 0 | $ 4.66M |
| 2013 | $ 3.37M | $ -3.52M | $ -3.67M | $ 0 | $ 6.27M |
| 2012 | $ 1.85M | $ -2.01M | $ -2.46M | $ 0 | $ 7.35M |
| 2011 | $ 0 | $ -1.77M | $ -2.69M | $ 0 | $ 3.44M |
| 2010 | $ 0 | $ -1.90M | $ -685.9K | $ 0 | $ 2.83M |
| 2009 | $ 0 | $ 3.92M | $ -3.77M | $ 0 | $ 7.0K |
| 2008 | $ 8.99M | $ -11.45M | $ -5.59M | $ 0 | $ 1.43M |
| 2007 | $ 687.4K | $ -31.62M | N/A | $ 0 | $ 8.56M |
| 2006 | $ 688.9K | $ -22.91M | N/A | $ 0 | $ 22.76M |
| 2005 | $ 4.84M | $ -21.22M | N/A | $ 0 | $ 11.25M |
| 2004 | N/A | N/A | N/A | $ 0 | $ 19.60M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.03 |
| Liabilities / Eq | 0.57 |
| Current Ratio | 0.61 |

## Other views

- [Metrics](https://sponda.capital/en/XTLB.md)
- [Charts](https://sponda.capital/en/XTLB/charts.md)
- [Compare](https://sponda.capital/en/XTLB/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.